Bicycle Therapeutics (BCYC) Earnings Date & Reports

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

BCYC is expected to report earnings to rise 12.89% to -84 cents per share on May 01

Bicycle Therapeutics BCYC Stock Earnings Reports

Q1'25

Est.

$-0.85

Q4'24

Beat

by $0.11

Q3'24

Beat

by $0.06

Q2'24

Beat

by $0.36

Q1'24

Beat

by $0.63

The last earnings report on February 25 showed earnings per share of -75 cents, beating the estimate of -86 cents. With 629.11K shares outstanding, the current market capitalization sits at 667.80M.

View a ticker or compare two or three

Compare

BCYC